Use of JAK inhibitors in the management of myelofibrosis: A revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibro... by Reilly, J, Mcmullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Mikhaeel, G, Gilleece, M, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Harrison, C

Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibro... by Reilly, J, McMullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Mikhaeel, G, Gilleece, M, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Harrison, C

Guideline for the diagnosis and management of myelofibrosis by Reilly, J, Mcmullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Michaeel, N, Gilleece, M, Hall, G, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Wilkins, B, Harrison, C

Guideline for the diagnosis and management of myelofibrosis. by Reilly, J, McMullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Michaeel, N, Gilleece, M, Hall, G, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Wilkins, B, Harrison, C

Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia by Craddock, C, Jackson, A, Loke, J, Siddique, S, Hodgkinson, A, Mason, J, Andrew, G, Nagra, S, Malladi, R, Peniket, A, Gilleece, M, Salim, R, Tholouli, E, Potter, V, Crawley, C, Wheatley, K, Protheroe, R, Vyas, P, Hunter, A, Parker, A, Wilson, K, Pavlu, J, Byrne, J, Dillon, R, Khan, N, McCarthy, N, Freeman, SD